Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Unknown 2Terminated 2Completed 2

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Lymphoma 2Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Kidney Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Cyclophosphamide 37Etoposide 25Vincristine 24Cytarabine 21Doxorubicin 19Rituximab 17Radiotherapy 17Peripheral Blood Stem Cell Transplantation 16Melphalan 16Prednisolone 14Methotrexate 14Filgrastim 13fludarabine phosphate 11Prednisone 11Dexamethasone 11Carmustine 9Bleomycin 9pegylated granulocyte colony-stimulating factor 8Cyclosporine 8Busulfan 8fludarabine 7Ifosfamide 7Cisplatin 7sargramostim 6Vinblastine 6Mitoxantrone 6Methylprednisolone 6Gemcitabine 6Chlorambucil 6Antilymphocyte Serum 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Lymphoma × keyhole-limpet hemocyanin × Clear all
NCT00017290 2013-12-04

Combination Chemotherapy Followed By Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Non-Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase 3 Unknown
Lymphoid

Lymphoma, Lymphoma, Follicular

NCT00091676 2012-02-03

BiovaxID

Biovest International

Phase 3 Unknown
629 enrolled
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡